BiotechTube
Home/NovAccess Global/Dr. Christopher Wheeler, Ph.D.
DC

Dr. Christopher Wheeler, Ph.D.

President, StemVax Therapeutics Inc.

NovAccess Global

Therapeutic Areas

OncologyNeurology

NovAccess Global Pipeline

DrugIndicationPhase
TLR-AD1Glioblastoma Multiforme (GBM)Pre-IND

Leadership Team at NovAccess Global

DD
Dr. Dwain Irvin, Ph.D., MPH
CEO, CFO, Executive Board Member
View full NovAccess Global profile